CVS Health EPS (Diluted) decreased by 0.4% to $2.30 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 63.1%, from $1.41 to $2.30. Over 4 years (FY 2021 to FY 2025), EPS (Diluted) shows a downward trend with a -30.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate stronger profitability even when accounting for potential share dilution.
Calculated by dividing net income by the weighted-average number of common shares outstanding, assuming the conversion o...
Used by all public companies to provide a realistic view of earnings per share for investors.
eps_diluted| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.10 | $1.20 | $1.04 | $1.77 | $2.29 | -$2.59 | $1.79 | $1.65 | $1.48 | $1.75 | $1.59 | $0.88 | $1.41 | $0.07 | $1.30 | $1.41 | $0.80 | -$3.13 | $2.31 | $2.30 |
| QoQ Change | — | -42.9% | -13.3% | +70.2% | +29.4% | -213.1% | +169.1% | -7.8% | -10.3% | +18.2% | -9.1% | -44.7% | +60.2% | -95.0% | >999% | +8.5% | -43.3% | -491.2% | +173.8% | -0.4% |
| YoY Change | — | — | — | — | +9.0% | -315.8% | +72.1% | -6.8% | -35.4% | +167.6% | -11.2% | -46.7% | -4.7% | -96.0% | -18.2% | +60.2% | -43.3% | <-999% | +77.7% | +63.1% |